IP Library Granted Patent US 11,718,874
Granted Patent B2
US 11,718,874 · App. 16/170,751 · Granted Aug 8, 2023

Hybridization chain reaction methods for in situ molecular detection

Inventors: Evan R. Daugharthy (Cambridge, MA); George M. Church (Brookline, MA)
Assignee: President and Fellows of Harvard College
C12Q1/6876C12N15/115C12Q1/682C12Q1/6806C12Q1/6816C12N2310/16C12N2320/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,718,874
App. No.
16/170,751
Granted
Aug 8, 2023
Kind
B2
Abstract

The disclosure provides a method for detecting a target analyte in a biological sample including contacting the sample with one or more probe sets each comprising a primary probe and a linker, contacting the sample with an initiator sequence, contacting the sample with a plurality of fluorescent DNA hairpins, wherein the probe binds the target molecule, the linker connects the probe to the initiator sequence, and wherein the initiator sequence nucleates with the cognate hairpin and triggers self-assembly of tethered fluorescent amplification polymers, and detecting the target molecule by measuring fluorescent signal of the sample.

Claims (25)

1. A method for identifying a plurality of target analytes in a sample, comprising:

(a) for each target analyte of said plurality of target analytes, contacting said sample with a probe coupled to a linker to bind said probe to said target analyte, wherein said linker is unique to said target analyte;

(b) subsequently adding a first hybridization chain reaction (HCR) initiator comprising an initiator sequence to said sample and contacting said sample with said first HCR initiator under conditions sufficient to permit said first HCR initiator to bind to said linker, wherein said first HCR initiator is separate from said probe, and wherein upon contacting said sample with said first HCR initiator, said linker couples said probe with said first HCR initiator;

(c) contacting said sample with HCR amplifiers to trigger a hybridization chain reaction, generating a first amplification product coupled to said probe;

(d) detecting said first amplification product;

(e) disrupting or reversing binding between said first HCR initiator and said linker;

(f) contacting said sample with a second HCR initiator comprising a second initiator sequence under conditions sufficient to permit said second HCR initiator to bind to said linker, wherein said second HCR initiator is separate from said probe, and wherein upon contacting said sample with said second HCR initiator, said linker couples said probe with said second HCR initiator;

(g) contacting said sample with additional HCR amplifiers to trigger an additional hybridization chain reaction, thereby generating a second amplification product coupled to said probe;

(h) detecting said second amplification product, and

(i) using at least signals from detecting said first amplification product and signals from detecting said second amplification product to generate a combined time-ordered composite signal unique for the each target analyte.

2. The method of claim 1 , wherein said disrupting or reversing comprises using toehold displacement to remove said first HCR initiator bound to said linker.

3. The method of claim 1 , further comprising generating said first amplification product or said second amplification product in situ.

4. The method of claim 1 , further comprising, detecting a spatial localization of said target analyte.

5. The method of claim 1 , wherein said probe comprises a protein, a peptide, an aptamer, a deoxyribonucleic acid hybridization probe, a ribonucleic acid hybridization probe, or any combination thereof.

6. The method of claim 1 , wherein said probe comprises a nucleotide sequence that is complementary to a sequence of said target analyte.

7. The method of claim 1 , wherein said probe comprises an antibody capable of binding to said target analyte.

8. The method of claim 1 , wherein said disrupting or reversing comprises using heat or a denaturant to remove said first HCR initiator bound to said linker.

9. The method of claim 1 , wherein said disrupting or reversing comprises using chemical, enzymatic, or light treatment that disrupts a linkage between said first HCR initiator and said linker.

10. The method of claim 1 , wherein an HCR amplifier of said HCR amplifiers comprises an HCR monomer that comprises a detectable label.

11. The method of claim 10 , wherein said detectable label comprises a fluorescent label.

12. The method of claim 10 , wherein said detectable label of said HCR monomer comprises a sequencing template for fluorescent sequencing and (d) comprises sequencing said sequencing template by fluorescent sequencing by hybridization, fluorescent sequencing by ligation, or fluorescent sequencing by synthesis.

13. The method of claim 10 , wherein said HCR monomer comprises one or more enzymatic or chemical sensitive groups, or photo-labile groups in a DNA backbone of said HCR monomer.

14. The method of claim 2 , wherein said toehold displacement comprises using a modified HCR monomer comprising one or more additional sequences for toehold strand displacement.

15. The method of claim 1 , wherein said target analyte is associated with a unique plurality of signals comprising signals detected from said first amplification product or said second amplification product.

16. The method of claim 1 , wherein said disrupting or reversing comprises cleaving said first HCR initiator.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2019
From: CHURCH, GEORGE M.; DAUGHARTHY, EVAN R.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 048264/0171 →
Continuity (3)
Continuation PCTUS2017029333 · Apr 25, 2017
Provisional Application 62326959 · Apr 25, 2016
Related Publication 20190218608A1 · Jul 18, 2019
Cited By (4)
US 12,203,136 US 12,534,751 US 12,540,355 US 12,559,790